help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herrington, J.
Right arrow Articles by Hille, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrington, J.
Right arrow Articles by Hille, B.

Endocrinology, Vol 135, 1100-1108, Copyright © 1994 by Endocrine Society


ARTICLES

Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms

J Herrington and B Hille
Department of Physiology and Biophysics, University of Washington, Seattle 98195.

The actions of GH-releasing hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys- NH2 or GHRP-6) on single rat somatotropes were studied using whole cell patch clamp electrophysiology and indo-1 Ca2+ photometry. GHRP-6 elevated intracellular free Ca2+ ([Ca2+]i) in two phases: a rapid transient phase, followed by a persistent phase. Based on its insensitivity to treatments that block Ca2+ entry [removal of external Ca2+, addition of the dihydropyridine Ca2+ channel blocker nitrendipine (1 microM), and the hyperpolarizing action of zero external Na+ or 100 nM somatostatin], the transient elevation is the result of release of Ca2+ from intracellular stores. The half-maximal concentration for the peak [Ca2+]i rise during Ca2+ release was 49 nM GHRP-6. Prior treatment of cells with caffeine (10 mM) or ryanodine (50 microM) abolished or partially occluded GHRP-6-induced Ca2+ release. Simultaneous measurement of [Ca2+]i and membrane current or potential revealed that the transient release of Ca2+ by GHRP-6 activates a voltage-independent Ca(2+)-activated K+ conductance, which transiently hyperpolarizes the somatotrope. The GHRP-6-induced persistent [Ca2+]i elevation is abolished by removal of external Ca2+ or external Na+ or the addition of 1 microM nitrendipine or 100 nM somatostatin, consistent with Ca2+ entry through voltage-dependent Ca2+ channels. In nondialyzed cells (perforated patch recording), we have identified a long-lasting GHRP-6- induced depolarization which may be responsible for the persistent [Ca2+]i elevation.


This article has been cited by other articles:


Home page
DiabetesHome page
K. Dezaki, M. Kakei, and T. Yada
Ghrelin Uses G{alpha}i2 and Activates Voltage-Dependent K+ Channels to Attenuate Glucose-Induced Ca2+ Signaling and Insulin Release in Islet {beta}-Cells: Novel Signal Transduction of Ghrelin
Diabetes, September 1, 2007; 56(9): 2319 - 2327.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
Endocr. Rev., June 1, 2004; 25(3): 426 - 457.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. M. Malagon, R. M. Luque, E. Ruiz-Guerrero, F. Rodriguez-Pacheco, S. Garcia-Navarro, F. F. Casanueva, F. Gracia-Navarro, and J. P. Castano
Intracellular Signaling Mechanisms Mediating Ghrelin-Stimulated Growth Hormone Release in Somatotropes
Endocrinology, December 1, 2003; 144(12): 5372 - 5380.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. J. H. Wong, J. D. Johnson, W. K. Yunker, and J. P. Chang
Caffeine stores and dopamine differentially require Ca2+ channels in goldfish somatotropes
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R494 - R503.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Weekers, E. Van Herck, J. Isgaard, and G. Van den Berghe
Pretreatment with Growth Hormone-Releasing Peptide-2 Directly Protects against the Diastolic Dysfunction of Myocardial Stunning in an Isolated, Blood-Perfused Rabbit Heart Model
Endocrinology, November 1, 2000; 141(11): 3993 - 3999.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. El Meskini, R. E. Mains, and B. A. Eipper
Cell Type-Specific Metabolism of Peptidylglycine {alpha}-Amidating Monooxygenase in Anterior Pituitary
Endocrinology, August 1, 2000; 141(8): 3020 - 3034.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Negishi, C. L. Chik, and A. K. Ho
Ceramide Enhances Growth Hormone (GH)-Releasing Hormone-Stimulated Cyclic Adenosine 3',5'-Monophosphate Accumulation but Inhibits GH Release in Rat Anterior Pituitary Cells
Endocrinology, December 1, 1999; 140(12): 5691 - 5697.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Shah, W. S. Evans, C. Y. Bowers, and J. D. Veldhuis
Tripartite Neuroendocrine Activation of the Human Growth Hormone (GH) Axis in Women by Continuous 24-Hour GH-Releasing Peptide Infusion: Pulsatile, Entropic, and Nyctohemeral Mechanisms
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2140 - 2150.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. L. Ramírez, J. P. Castaño, R. Torronteras, A. J. Martínez-Fuentes, L. S. Frawley, S. García-Navarro, and F. Gracia-Navarro
Growth Hormone (GH)-Releasing Factor Differentially Activates Cyclic Adenosine 3',5'-Monophosphate- and Inositol Phosphate-Dependent Pathways to Stimulate GH Release in Two Porcine Somatotrope Subpopulations
Endocrinology, April 1, 1999; 140(4): 1752 - 1759.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. M. Skinner, R. Nass, B. Lopes, E. R. Laws, and M. O. Thorner
Growth Hormone Secretagogue Receptor Expression in Human Pituitary Tumors
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4314 - 4320.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Nielsen, S. Mellemkjær, L. M. Rasmussen, T. Ledet, J. Astrup, J. Weeke, and J. O. L. Jørgensen
Gene Transcription of Receptors for Growth Hormone-Releasing Peptide and Somatostatin in Human Pituitary Adenomas
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2997 - 3000.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Billiard, D.-S. Koh, D. F. Babcock, and B. Hille
Protein kinase C as a signal for exocytosis
PNAS, October 28, 1997; 94(22): 12192 - 12197.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. G. Smith, L. H. T. Van der Ploeg, A. D. Howard, S. D. Feighner, K. Cheng, G. J. Hickey, M. J. Wyvratt Jr., M. H. Fisher, R. P. Nargund, and A. A. Patchett
Peptidomimetic Regulation of Growth Hormone Secretion
Endocr. Rev., October 1, 1997; 18(5): 621 - 645.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Sundaresan, J. Weiss, A. C. Bauer-Dantoin, and J. L. Jameson
Expression of Ryanodine Receptors in the Pituitary Gland: Evidence for a Role in Gonadotropin-Releasing Hormone Signaling
Endocrinology, May 1, 1997; 138(5): 2056 - 2065.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Andric, T. S. Kostic, M. Tomic', T.-a. Koshimizu, and S. S. Stojilkovic
Dependence of Soluble Guanylyl Cyclase Activity on Calcium Signaling in Pituitary Cells
J. Biol. Chem., January 5, 2001; 276(1): 844 - 849.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. D. Johnson, C. Klausen, H. R. Habibi, and J. P. Chang
Function-specific calcium stores selectively regulate growth hormone secretion, storage, and mRNA level
Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E810 - E819.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society